Traws Pharma Inc (TRAW) Directors and Executive Officers

Officers & Directors

Peter Atadja, P.H.D. - Director

Trafford Clarke, P.H.D. - Director

Viren Mehta, P.H.D. - Director

Jerome E. Groopman, M.D. - Director

Jack E. Stover - Director

James J. Marino - Chairman, Board of Directors

Steven M. Fruchtman, M.D. - Director, President and Chief Executive Officer (Principal Executive Officer)

Mark Guerin - Chief Operating Officer and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Mary Teresa Shoemaker - Director,

Traws Pharma inc currently has 17 employees.

News about Traws Pharma inc Key Personnel

Leadership Shake-Up at Traws Pharma Amid Promising Breakthrough in Bird Flu Treatment

Traws Pharma in Transition: Charting a Course through Financial Struggles and Promising InnovationsNEWTOWN, Pa.—In a surprising move, Traws Pharma, Inc. (NASDAQ: TRAW), a clinical-stage biopharmaceutical company at the forefront of developing therapies against respiratory viral diseases, announced the retirement of its Chief Executive Officer, Dr. Werner Cautreels, effective March 31, 2025. The announcement comes on the heels of a string of mixed financial results and a significant milestone in the company’s antiviral research.Dr. Iain D. Dukes, a seasoned biopharma veteran and the current Chairman, will step in as Interim CEO during this pivotal time. While the leadership change raises eyebrows, Traw...